ANNX Latest Press Releases

-- November 12, 2025 --

Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants Globe Newswire 10:55 PM

Annexon Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Globe Newswire 4:12 PM

-- November 10, 2025 --

Annexon Reports Third Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones Globe Newswire 4:05 PM

-- August 27, 2025 --

Annexon Biosciences to Participate in Upcoming September Investor Conferences Globe Newswire 8:00 AM

-- August 18, 2025 --

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- August 14, 2025 --

Annexon Reports Second Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones Globe Newswire 4:05 PM

-- August 7, 2025 --

Annexon Selected by EMA to Participate in Product Development Coordinator Pilot for Vonaprument (ANX007) for Dry Age-Related Macular Degeneration with Geographic Atrophy Globe Newswire 4:30 PM

-- July 24, 2025 --

Annexon Completes Enrollment In Pivotal Phase 3 ARCHER II Trial Of Vonaprument For Dry Age-Related Macular Degeneration With Geographic Atrophy Benzinga Newsdesk 7:05 AM

Annexon Announces Completion of Enrollment in Pivotal Phase 3 ARCHER II Trial of Vonaprument (formerly ANX007) for Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software